Michał Sobjanek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Michał Sobjanek has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Roman Nowicki
Department of Dermatology, Venereology and Allergology, Faculty of Medicine Medical University of Gdańsk Gdańsk Poland
13 shared publications - Małgorzata Sokołowska-Wojdyło
Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdańsk, Poland
10 shared publications - Bogusław Nedoszytko
Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdańsk, Poland
9 shared publications Monika Zabłotna
Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland
7 shared publicationsIgor Michajłowski
Department of Dermatology, Venerology and Allergology, Medical University of Gdańsk, Gdańsk, Poland
6 shared publicationsMonika Sikorska
Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland
4 shared publications
Latest Publications
- 31 January 2017
- Published by "Medycyna Praktyczna" Spolka Jawna in Polish Archives of Internal Medicine
- Vol. 127 (1) , 66-67
Keratoacanthoma‑like cutaneous metastases as the first presentation of lung cancer
- 31 January 2017
- Published by "Medycyna Praktyczna" Spolka Jawna in Polish Archives of Internal Medicine
- Vol. 127 (1) , 66-67
Keratoacanthoma‑like cutaneous metastases as the first presentation of lung cancer
- Open Access
- 1 January 2017
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 1 (1) , 85-86
The significance of Toll-like receptor (TLR) 2 and 9 gene polymorphisms in psoriasis
- 1 January 2017
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 1 (1) , 85-86
Open AccessThe significance of Toll-like receptor (TLR) 2 and 9 gene polymorphisms in psoriasis
- Open Access
- 1 January 2017
- Published by Termedia Sp. z.o.o. in Dermatology Review
- Vol. 1 (1) , 64-65
Penile changes due to genital pearling (fang muk)
- 1 January 2017
- Published by Termedia Sp. z.o.o. in Dermatology Review
- Vol. 1 (1) , 64-65
Open AccessPenile changes due to genital pearling (fang muk)
- Open Access
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Dermatology Review
- Vol. 6, 498-499
Skin lesions caused by bortezomib targeted therapy of multiple myeloma
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Dermatology Review
- Vol. 6, 498-499
Open AccessSkin lesions caused by bortezomib targeted therapy of multiple myeloma
- Open Access
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 4 (4) , 263-268
Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma
Introduction: Basal cell carcinoma (BCC) is an immunogenic neoplasm and the imbalance in Th1/Th2 cytokines expression seems to play the major role in pathogenesis and clinical behaviour of the tumour. Aim : To investigate the association of soluble interleukin 2α receptor (sIL-2Rα) and...
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 4 (4) , 263-268
Open AccessSoluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma
Introduction: Basal cell carcinoma (BCC) is an immunogenic neoplasm and the imbalance in Th1/Th2 cytokines expression seems to play the major role in pathogenesis and clinical behaviour of the tumour. Aim : To investigate the association of soluble interleukin 2α receptor (sIL-2Rα) and...
- Open Access
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 5 (5) , 381-385
–2518 A/G MCP-1 but not –403 G/A RANTES gene polymorphism is associated with enhanced risk of basal cell carcinoma
Introduction : Polymorphic variants of MCP-1 and RANTES genes and their protein serum levels have been implicated in the increased risk and severity of several malignancies. However, the subject has not been explored in basal cell carcinoma (BCC) patients so far. Aim : To investigate the...
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 5 (5) , 381-385
Open Access–2518 A/G MCP-1 but not –403 G/A RANTES gene polymorphism is associated with enhanced risk of basal cell carcinoma
Introduction : Polymorphic variants of MCP-1 and RANTES genes and their protein serum levels have been implicated in the increased risk and severity of several malignancies. However, the subject has not been explored in basal cell carcinoma (BCC) patients so far. Aim : To investigate the...
- 1 January 2015
- Published by Termedia Sp. z.o.o. in Dermatology Review
- Vol. 6, 569-570
Segmental neurofibromatosis – two other Polish cases
- 1 January 2015
- Published by Termedia Sp. z.o.o. in Dermatology Review
- Vol. 6, 569-570
Segmental neurofibromatosis – two other Polish cases
- 1 January 2015
- Published by Termedia Sp. z.o.o. in Dermatology Review
- Vol. 1, 51-52
Letters to the editors Vitiligo and lichen planus – common etiopathogenesis or coincidence?
- 1 January 2015
- Published by Termedia Sp. z.o.o. in Dermatology Review
- Vol. 1, 51-52
Letters to the editors Vitiligo and lichen planus – common etiopathogenesis or coincidence?
- Open Access
- 1 January 2015
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 3 (3) , 599-604
–308 G/A TNF-α gene polymorphism influences the course of basal cell carcinoma in a Polish population
Introduction : The etiopathogenesis of basal cell carcinoma (BCC) is multifactorial. The TNF-α gene seems to be an interesting gene candidate for BCC susceptibility because of the proinflammatory and immunosuppressive properties of its product. The aim of the study was to assess the frequency...
- 1 January 2015
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 3 (3) , 599-604
Open Access–308 G/A TNF-α gene polymorphism influences the course of basal cell carcinoma in a Polish population
Introduction : The etiopathogenesis of basal cell carcinoma (BCC) is multifactorial. The TNF-α gene seems to be an interesting gene candidate for BCC susceptibility because of the proinflammatory and immunosuppressive properties of its product. The aim of the study was to assess the frequency...
- Open Access
- 6 June 2014
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 306 (6) , 539-544
The −1154 G/A VEGF gene polymorphism is associated with the incidence of basal cell carcinoma in patients from northern Poland
Vascular endothelial growth factor (VEGF) is believed to play a crucial role in neoplastic angiogenesis. Although the genetic background of basal cell carcinoma (BCC) has been analyzed in some papers, the mechanism of BCC pathogenesis is not fully understood. To the best of our knowledge, VEGF gene polymorphisms have not yet been explored. The aim of the study was to asses the frequency of three polymorphisms in the VEGF gene (−1154 G/A, −460 T/C and +405 G/C) in patients of Polish origin with BCC and control group. In addition, VEGF serum levels of patients with BCC and controls were measured. The study involved 180 patients (96 women, 84 men) with BCC and a mean age of 68.9 ± 11.8, and 215 healthy age- and sex-matched volunteers. The VEGF polymorphisms at positions −1154 and +405 were analyzed using the amplification refractory mutation system polymerase chain reaction method. To assess the VEGF gene polymorphism at position −460, we used the polymerase chain reaction restriction fragment length polymorphism method. Serum levels of VEGF protein were measured using the ELISA test. The presence of the G allele (GA or GG) in the −1154 VEGF polymorphism was associated with an increased risk of BCC development (OR = 7.28, p < 0.0001). Furthermore, the carriers of the AA genotype in −1154 VEGF polymorphism showed significantly reduced risks of BCC (OR = 0.14, p < 0.0001). It was also shown that the GTC haplotype of VEGF predisposes to BCC development (OR = 1.69, p = 0.013), while the presence of the ATG haplotype significantly reduces this risk (OR = 0.17, p = 0.00001). We have found significantly increased VEGF serum levels among BCC patients, in comparison with the healthy controls (mean 596.7 ± 393.5 pg/ml; range 60.1–931.4 vs. 255.9 ± 174.6 pg/ml; range 42.2–553.0 pg/ml; p < 0.0004). The serum levels of VEGF significantly correlated with tumor size: r = 0.41, p < 0.0001. Our results testify to the importance of −1154 G/A VEGF gene polymorphisms in altering the risk of BCC among the population from northern Poland.
- 6 June 2014
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 306 (6) , 539-544
Open AccessThe −1154 G/A VEGF gene polymorphism is associated with the incidence of basal cell carcinoma in patients from northern Poland
Vascular endothelial growth factor (VEGF) is believed to play a crucial role in neoplastic angiogenesis. Although the genetic background of basal cell carcinoma (BCC) has been analyzed in some papers, the mechanism of BCC pathogenesis is not fully understood. To the best of our knowledge, VEGF gene polymorphisms have not yet been explored. The aim of the study was to asses the frequency of three polymorphisms in the VEGF gene (−1154 G/A, −460 T/C and +405 G/C) in patients of Polish origin with BCC and control group. In addition, VEGF serum levels of patients with BCC and controls were measured. The study involved 180 patients (96 women, 84 men) with BCC and a mean age of 68.9 ± 11.8, and 215 healthy age- and sex-matched volunteers. The VEGF polymorphisms at positions −1154 and +405 were analyzed using the amplification refractory mutation system polymerase chain reaction method. To assess the VEGF gene polymorphism at position −460, we used the polymerase chain reaction restriction fragment length polymorphism method. Serum levels of VEGF protein were measured using the ELISA test. The presence of the G allele (GA or GG) in the −1154 VEGF polymorphism was associated with an increased risk of BCC development (OR = 7.28, p < 0.0001). Furthermore, the carriers of the AA genotype in −1154 VEGF polymorphism showed significantly reduced risks of BCC (OR = 0.14, p < 0.0001). It was also shown that the GTC haplotype of VEGF predisposes to BCC development (OR = 1.69, p = 0.013), while the presence of the ATG haplotype significantly reduces this risk (OR = 0.17, p = 0.00001). We have found significantly increased VEGF serum levels among BCC patients, in comparison with the healthy controls (mean 596.7 ± 393.5 pg/ml; range 60.1–931.4 vs. 255.9 ± 174.6 pg/ml; range 42.2–553.0 pg/ml; p < 0.0004). The serum levels of VEGF significantly correlated with tumor size: r = 0.41, p < 0.0001. Our results testify to the importance of −1154 G/A VEGF gene polymorphisms in altering the risk of BCC among the population from northern Poland.